Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Judicious use of anorectics].

A Laurent-Jaccard1

  • 1Policlinique médicale universitaire, Lausanne.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|February 5, 1991
PubMed
Summary

Physicians should reconsider drug therapy for obesity. Dextro-fenfluramine offers appetite suppression and aids in managing eating disorders, complementing diet and behavioral support.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Are PUFAs n-3 really important in diet?].

Revue medicale suisse·2006
Same author

[Are food preferences affected by body mass index, age, sex or tobacco?].

Schweizerische medizinische Wochenschrift·1994
Same author

[Handicaps of massive obesity].

La Revue du praticien·1993
Same author

[Follow-up of patients after gastroplasty].

Revue medicale de la Suisse romande·1992
Same author

[Obesity: indications for surgery].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1990
Same author

[From psychiatrist to family physician or return to sender].

Revue medicale de la Suisse romande·1988

Area of Science:

  • Pharmacology
  • Endocrinology
  • Behavioral Science

Context:

  • Physicians often avoid pharmacotherapy for adipose patients.
  • Recent advancements in obesity research necessitate a re-evaluation of drug-therapy.
  • Current attitudes towards anti-obesity medications require discussion.

Purpose:

  • To discuss the role of drug therapy in obesity management.
  • To explore the mechanisms and applications of specific anorectic agents.
  • To highlight the importance of integrated treatment approaches for obesity.

Summary:

  • Amphetamine-group anorectics and analogues act on the noradrenergic system for appetite suppression.
  • Dextro-fenfluramine influences serotonin release, reducing food intake and increasing satiety.
  • The study examines Dextro-fenfluramine's use in eating disorders, side effects, and administration, emphasizing combined therapy.

Impact:

  • Encourages physicians to consider pharmacotherapy in obesity treatment.
  • Provides insights into the efficacy of Dextro-fenfluramine for specific eating behaviors.
  • Underscores the necessity of combining medication with diet and behavioral interventions for successful weight management.

Related Experiment Videos